We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » UK-Based Smiths Group Gets Warning Letter for GMP, QS Violations
UK-Based Smiths Group Gets Warning Letter for GMP, QS Violations
June 9, 2006
The FDA issued a May 24 warning letter to UK-based Smiths Group, also known as Smiths Specialty Engineering, which manufactures insulin pumps.